Autor: "Jan, J." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials.
Autorzy:: Haussmann J; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany. jan..
Budach W; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Corradini S; Department of Radiation Oncology, Ludwig Maximillian University, Munich, Germany.
Krug D; Department of Radiation Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
Jazmati D; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Tamaskovics B; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Bölke E; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Pedotoa A; Department of Anesthesiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Kammers K; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, USA.
Matuschek C; Department of Radiation Oncology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.; Pokaż więcej
Źródło:: Radiation oncology (London, England) [Radiat Oncol] 2023 Nov 02; Vol. 18 (1), pp. 181. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:: Systematic Review; Meta-Analysis; Journal Article
MeSH Terms:: Quality of Life*
Breast Neoplasms*/radiotherapy
Breast Neoplasms*/surgery
Humans ; Female ; Treatment Outcome ; Randomized Controlled Trials as Topic ; Breast ; Mastectomy, Segmental

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Mitochondrial heteroplasmic shifts reveal a positive selection of breast cancer.
Autorzy:: Li Y; Center for Primary Health Care Research, Lund University/Region Skåne, Malmö, Sweden. .; Center for Primary Health Care Research Wallenberg Laboratory, Skåne University Hospital, 5th floor, Inga Marie Nilssons gata 53, S-205 02, Malmö, Sweden. .
Sundquist K; Center for Primary Health Care Research, Lund University/Region Skåne, Malmö, Sweden.; Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Functional Pathology, Center for Community-Based Healthcare Research and Education (CoHRE), School of Medicine, Shimane University, Matsue, Japan.
Vats S; Center for Primary Health Care Research, Lund University/Region Skåne, Malmö, Sweden.
Hong MG; Science for Life Laboratory, Department of Biochemistry and Biophysics, National Bioinformatics Infrastructure Sweden, Stockholm University, Solna, Sweden.
Wang X; Center for Primary Health Care Research, Lund University/Region Skåne, Malmö, Sweden.
Chen Y; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund, Sweden.
Hedelius A; Center for Primary Health Care Research, Lund University/Region Skåne, Malmö, Sweden.
Saal LH; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund, Sweden.
Sundquist J; Center for Primary Health Care Research, Lund University/Region Skåne, Malmö, Sweden.; Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Functional Pathology, Center for Community-Based Healthcare Research and Education (CoHRE), School of Medicine, Shimane University, Matsue, Japan.
Memon AA; Center for Primary Health Care Research, Lund University/Region Skåne, Malmö, Sweden.; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2023 Oct 05; Vol. 21 (1), pp. 696. Date of Electronic Publication: 2023 Oct 05.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/genetics
Middle Aged ; Humans ; Female ; Case-Control Studies ; Mutation/genetics ; DNA, Mitochondrial/genetics ; Germ-Line Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Autorzy:: Morra A; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Schreurs MAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Anton-Culver H; Department of Medicine, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, California, USA.
Augustinsson A; Oncology, Clinical Sciences in Lund, Lund University, Lund, Sweden.
Beckmann MW; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Bojesen SE; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Brauch H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; iFIT-Cluster of Excellence, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Tübingen, Germany.
Broeks A; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Buys SS; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Camp NJ; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Castelao JE; Oncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
Cessna MH; Intermountain Healthcare, Salt Lake City, Utah, USA.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Chung WK; Departments of Pediatrics and Medicine, Columbia University, New York, New York, USA.
Colonna SV; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Cox A; Department of Oncology and Metabolism, Sheffield Institute for Nucleic Acids (SInFoNiA), University of Sheffield, Sheffield, UK.
Cross SS; Department of Neuroscience, Academic Unit of Pathology, University of Sheffield, Sheffield, UK.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Devilee P; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Dunning AM; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Dwek M; School of Life Sciences, University of Westminster, London, UK.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Eccles DM; Faculty of Medicine, University of Southampton, Southampton, UK.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Evans DG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
Fehm TN; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Figueroa JD; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.; Cancer Research UK Edinburgh Centre, The University of Edinburgh, Edinburgh, UK.; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Flyger H; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
Gabrielson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Gago-Dominguez M; Cancer Genetics and Epidemiology Group, SERGAS, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Foundation, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
García-Closas M; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
García-Sáenz JA; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Genkinger J; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.; Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
Grassmann F; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Health and Medical University, Potsdam, Germany.
Gündert M; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.; Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Harrington PA; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Hartikainen JM; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.
Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Howell A; Division of Cancer Sciences, University of Manchester, Manchester, UK.
Jakubowska A; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
Janni W; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Jernström H; Oncology, Clinical Sciences in Lund, Lund University, Lund, Sweden.
John EM; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Johnson N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Kristensen VN; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
Kurian AW; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Lambrechts D; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Lubiński J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Lux MP; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Biobank of Eastern Finland, Kuopio University Hospital, Kuopio, Finland.
Mavroudis D; Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
Mulligan AM; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Muranen TA; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Nevelsteen I; Department of Oncology, Leuven Multidisciplinary Breast Center, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Neven P; Department of Oncology, Leuven Multidisciplinary Breast Center, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Newman WG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Obi N; Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Offit K; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Olshan AF; Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Park-Simon TW; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Patel AV; Department of Population Science, American Cancer Society, Atlanta, Georgia, USA.
Peterlongo P; IFOM ETS - The AIRC Institute of Molecular Oncology, Genome Diagnostics Program, Milan, Italy.
Phillips KA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
Plaseska-Karanfilska D; Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', MASA, Skopje, Republic of North Macedonia.
Polley EC; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Presneau N; School of Life Sciences, University of Westminster, London, UK.
Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland.
Rack B; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Radice P; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 'Predictive Medicine: Molecular Bases of Genetic Risk', Milan, Italy.
Rashid MU; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan.
Rhenius V; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Robson M; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Romero A; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
Saloustros E; Department of Oncology, University Hospital of Larissa, Larissa, Greece.
Sawyer EJ; School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, King's College London, London, UK.
Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Schuetze S; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Scott C; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Shah M; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Smichkoska S; Medical Faculty, University Clinic of Radiotherapy and Oncology, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.
Southey MC; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Tapper WJ; Faculty of Medicine, University of Southampton, Southampton, UK.
Teras LR; Department of Population Science, American Cancer Society, Atlanta, Georgia, USA.
Tollenaar RAEM; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
Tomczyk K; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Tomlinson I; Cancer Research Centre, The University of Edinburgh, Edinburgh, UK.
Troester MA; Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Vachon CM; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
van Veen EM; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wendt C; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
Wildiers H; Department of Oncology, Leuven Multidisciplinary Breast Center, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland.
Ziogas A; Department of Medicine, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, California, USA.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
Adank MA; Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Pokaż więcej
Corporate Authors:: NBCS Collaborators; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Research, Vestre Viken Hospital, Drammen, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Division of Surgery, Cancer and Transplantation Medicine, Department of Oncology, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Oslo Breast Cancer Research Consortium, Oslo University Hospital, Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Community Medicine, The Arctic University of Norway, Tromsø, Norway.; Core Facility for Biobanking, The Arctic University of Norway, Tromsø, Norway.
ABCTB Investigators; Australian Breast Cancer Tissue Bank, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
kConFab Investigators; Research Department, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Źródło:: Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (15), pp. 16142-16162. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:: Breast Neoplasms*/genetics
Breast Neoplasms*/radiotherapy
Female ; Humans ; Checkpoint Kinase 2/genetics ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Heterozygote ; Proportional Hazards Models

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Murine Breast Cancer Radiosensitization Using Oxygen Microbubbles and Metformin: Vessels Are the Key.
Autorzy:: Drzał A; Faculty of Biochemistry, Biophysics and Biotechnology, Department of Biophysics and Cancer Biology, Jagiellonian University, 30-387 Krakow, Poland.
Dziurman G; Faculty of Biochemistry, Biophysics and Biotechnology, Department of Biophysics and Cancer Biology, Jagiellonian University, 30-387 Krakow, Poland.; Doctoral School of Exact and Natural Sciences, Faculty of Biochemistry, Biophysics and Biotechnology, Department of Biophysics and Cancer Biology, Jagiellonian University, 30-387 Krakow, Poland.
Hoła P; Faculty of Biochemistry, Biophysics and Biotechnology, Department of Biophysics and Cancer Biology, Jagiellonian University, 30-387 Krakow, Poland.
Lechowski J; Faculty of Biochemistry, Biophysics and Biotechnology, Department of Biophysics and Cancer Biology, Jagiellonian University, 30-387 Krakow, Poland.
Delalande A; UFR Sciences and Techniques, University of Orleans, 45067 Orleans, France.; Center for Molecular Biophysics, CNRS Orleans, 45071 Orleans, France.
Swakoń J; Institute of Nuclear Physics, Polish Academy of Sciences, 31-342 Krakow, Poland.
Pichon C; UFR Sciences and Techniques, University of Orleans, 45067 Orleans, France.; Center for Molecular Biophysics, CNRS Orleans, 45071 Orleans, France.; Institut Universitaire de France, 75231 Paris, France.
Elas M; Faculty of Biochemistry, Biophysics and Biotechnology, Department of Biophysics and Cancer Biology, Jagiellonian University, 30-387 Krakow, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 29; Vol. 24 (15). Date of Electronic Publication: 2023 Jul 29.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/radiotherapy
Metformin*/pharmacology
Metformin*/therapeutic use
Mice ; Humans ; Animals ; Female ; Microbubbles ; Oxygen ; Tumor Hypoxia

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses.
Autorzy:: Ye J; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 1000 37 Convent Dr, Bethesda, MD, 20892, USA.
Wang H; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 1000 37 Convent Dr, Bethesda, MD, 20892, USA.
Medina R; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 1000 37 Convent Dr, Bethesda, MD, 20892, USA.
Chakraborty S; NE1 Inc, New York, NY, USA.
Sun M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 1000 37 Convent Dr, Bethesda, MD, 20892, USA.
Valenzuela A; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 1000 37 Convent Dr, Bethesda, MD, 20892, USA.; David Geffen School of Medicine, University of California, Los Angeles, CA, USA.; Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA.
Sang X; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 1000 37 Convent Dr, Bethesda, MD, 20892, USA.
Zhang Y; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 1000 37 Convent Dr, Bethesda, MD, 20892, USA.
Uher O; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Zenka J; Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
Pacak K; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Zhuang Z; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 37, Room 1000 37 Convent Dr, Bethesda, MD, 20892, USA. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Jul 12; Vol. 42 (1), pp. 163. Date of Electronic Publication: 2023 Jul 12.
Typ publikacji:: Journal Article
MeSH Terms:: Cancer Vaccines*/therapeutic use
Melanoma*
Breast Neoplasms*/therapy
Animals ; Mice ; Humans ; Female ; Mannans ; Immunologic Memory ; CD40 Antigens ; Antigens, Neoplasm

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Eligibility criteria in clinical trials in breast cancer: a cohort study.
Autorzy:: Szlezinger K; Pharmacovigilance Department, Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Aleje Jerozolimskie 181C, 02-222, Warsaw, Poland.
Pogoda K; Department of Breast Cancer and Reconstruction Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Roentgena 5, 02-781, Warsaw, Poland.
Jagiełło-Gruszfeld A; Department of Breast Cancer and Reconstruction Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Roentgena 5, 02-781, Warsaw, Poland.
Kłosowska D; Department of Clinical Immunology, Medical University of Warsaw, Nowogrodzka 59, 02-006, Warsaw, Poland.
Górski A; Bacteriophage Laboratory, Department of Phage Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfe Weigla 12, 53-114, Wrocław, Poland.
Borysowski J; Department of Clinical Immunology, Medical University of Warsaw, Nowogrodzka 59, 02-006, Warsaw, Poland. jan..; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2023 Jul 03; Vol. 21 (1), pp. 240. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/epidemiology
Breast Neoplasms*/therapy
Humans ; Female ; Aged ; Cohort Studies ; Comorbidity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: The Role of Cocaine- and Amphetamine-Regulated Transcript (CART) in Cancer: A Systematic Review.
Autorzy:: Owe-Larsson M; Department of Histology and Embryology, Center of Biostructure Research, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland.
Pawłasek J; Department of Histology and Embryology, Center of Biostructure Research, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland.
Piecha T; Department of General, Oncological and Functional Urology, Medical University of Warsaw, Lindleya 4, 02-005 Warsaw, Poland.
Sztokfisz-Ignasiak A; Department of Histology and Embryology, Center of Biostructure Research, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland.
Pater M; Department of Histology and Embryology, Center of Biostructure Research, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland.
Janiuk IR; Department of Histology and Embryology, Center of Biostructure Research, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 10; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 10.
Typ publikacji:: Systematic Review; Journal Article; Review
MeSH Terms:: Neuroendocrine Tumors*
Breast Neoplasms*
Cocaine*
Humans ; Female ; Nerve Tissue Proteins/metabolism ; Tamoxifen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: ATP13A4 Upregulation Drives the Elevated Polyamine Transport System in the Breast Cancer Cell Line MCF7.
Autorzy:: van Veen S; Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.
Kourti A; Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.
Ausloos E; Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.
Van Asselberghs J; Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Van den Haute C; Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.; Leuven Viral Vector Core, KU Leuven, 3000 Leuven, Belgium.
Baekelandt V; Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Eggermont J; Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.
Vangheluwe P; Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2023 May 31; Vol. 13 (6). Date of Electronic Publication: 2023 May 31.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/metabolism
Polyamines*/metabolism
Female ; Humans ; Adenosine Triphosphatases/genetics ; Biological Transport ; MCF-7 Cells ; Membrane Transport Proteins/metabolism ; Up-Regulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?
Autorzy:: Vets J; Translational Cell and Tissue Research Laboratory, KU Leuven, Leuven, Belgium.
Marcelis L; Translational Cell and Tissue Research Laboratory, KU Leuven, Leuven, Belgium.; Department of Pathology, UZ Leuven, University Hospitals, Leuven, Belgium.
Schepers C; Department of Pathology, UZ Leuven, University Hospitals, Leuven, Belgium.
Dorreman Y; Department of Oncological Surgery, UZ Ghent, Brugge, Belgium.
Verbeek S; Department of Pathology, ZOL, Genk, Belgium.
Vanwalleghem L; Department of Pathology, AZ Sint-Jan, Brugge, Belgium.
Gieraerts K; Department of Radiology, AZ Sint-Jan, Brugge, Belgium.
Meylaerts L; Department of Radiology, ZOL, Genk, Belgium.
Lesaffer J; Department of Oncological Surgery, Sint-Jan, Brugge, AZ, Belgium.
Devos H; Department of Laboratory Medicine, AZ Sint-Jan, Brugge, Belgium.
Put N; Department of Hematology, ZOL, Genk, Belgium.
Snauwaert S; Department of Hematology, AZ Sint-Jan, Brugge, Belgium.
De Paepe P; Department of Pathology, AZ Sint-Jan, Brugge, Belgium.
Tousseyn T; Translational Cell and Tissue Research Laboratory, KU Leuven, Leuven, Belgium. .; Department of Pathology, UZ Leuven, University Hospitals, Leuven, Belgium. .; Pokaż więcej
Źródło:: Diagnostic pathology [Diagn Pathol] 2023 Apr 25; Vol. 18 (1), pp. 52. Date of Electronic Publication: 2023 Apr 25.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Implants*/adverse effects
HIV Infections*
Breast Neoplasms*/pathology
Lymphoma, Large-Cell, Anaplastic*/diagnosis
Lymphoma, Large-Cell, Anaplastic*/etiology
Lymphoma, Large-Cell, Anaplastic*/pathology
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Humans ; Female ; Herpesvirus 4, Human ; Ki-1 Antigen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer.
Autorzy:: Korbecki J; Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.; Department of Anatomy and Histology, Collegium Medicum, University of Zielona Góra, Zyty 28 Str., 65-046 Zielona Góra, Poland.
Bosiacki M; Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.; Department of Functional Diagnostics and Physical Medicine, Faculty of Health Sciences Pomeranian Medical University in Szczecin, Żołnierska 54 Str., 71-210 Szczecin, Poland.
Barczak K; Department of Conservative Dentistry and Endodontics, Pomeranian Medical University, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
Łagocka R; Department of Conservative Dentistry and Endodontics, Pomeranian Medical University, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
Brodowska A; Department of Gynecology, Endocrinology and Gynecological Oncology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.
Chlubek D; Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
Baranowska-Bosiacka I; Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Apr 14; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 14.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Breast Neoplasms*
Uterine Cervical Neoplasms*/genetics
Endometrial Neoplasms*/genetics
Prostatic Neoplasms*
Ovarian Neoplasms*
Male ; Humans ; Female ; Ligands ; Clinical Relevance ; Chemokine CXCL1/genetics ; Carcinogenesis ; Cell Transformation, Neoplastic ; Receptors, Interleukin-8B ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
Autorzy:: Hakkaart C; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Pearson JF; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Marquart L; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; School of Public Health, University of Queensland, Brisbane, Australia.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wiggins GAR; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Barnes DR; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Robinson BA; Department of Medicine, University of Otago, Christchurch, New Zealand.; Canterbury Regional Cancer and Haematology Service, Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand.
Mace PD; Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Aittomäki K; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.
Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Arun BK; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Azzollini J; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Balmaña J; Hereditary cancer Genetics Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Hospital Campus, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Barkardottir RB; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.; BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Belhadj S; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Berger L; Department of Clinical Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Blok MJ; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
Boonen SE; Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark.
Borde J; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Bradbury AR; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), ONCOBELL-IDIBELL-IGTP, CIBERONC, Barcelona, Spain.
Buys SS; Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Caligo MA; SOD Genetica Molecolare, University Hospital, Pisa, Italy.
Campbell I; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Chung WK; Departments of Pediatrics and Medicine, Columbia University, New York, NY, USA.
Claes KBM; Centre for Medical Genetics, Ghent University Hospital, Gent, Belgium.
Collonge-Rame MA; Service de Génétique Biologique, CHRU de Besançon, Besançon, France.
Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
Cosgrove C; Gynecologic Oncology, Translational Therapeutics, Department of Obstetrics and Gynecology, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
Dandiker S; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Davidson R; Department of Clinical Genetics, Queen Elizabeth University Hospital, Glasgow, UK.
de la Hoya M; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
de Putter R; Centre for Medical Genetics, Ghent University Hospital, Gent, Belgium.
Delnatte C; Oncogénétique, Institut de Cancérologie de l'Ouest siteRené Gauducheau, Saint Herblain, France.
Dhawan M; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA, USA.
Diez O; Hereditary cancer Genetics Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Hospital Campus, Barcelona, Spain.; Area of Clinical and Molecular Genetics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Ding YC; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Domchek SM; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Donaldson A; Clinical Genetics Department, St Michael's Hospital, Bristol, UK.
Eason J; Nottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Ehrencrona H; Department of Clinical Genetics and Pathology, Laboratory Medicine, Skåne University Hospital, Lund, Sweden.; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Evans DG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Faust U; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Feliubadaló L; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), ONCOBELL-IDIBELL-IGTP, CIBERONC, Barcelona, Spain.
Fostira F; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece.
Friedman E; The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Frone M; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Garber J; Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA.
Gayther SA; Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Gehrig A; Department of Human Genetics, University Würzburg, Würzburg, Germany.
Gesta P; Service Régional Oncogénétique Poitou-Charentes, CH Niort, Niort, France.
Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Hahnen E; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Hake CR; Waukesha Memorial Hospital-Pro Health Care, Waukesha, USA.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hansen TVO; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Hauke J; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Hentschel J; Institute of Human Genetics, University Hospital Leipzig, Leipzig, Germany.
Herold N; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Honisch E; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Hulick PJ; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA.; The University of Chicago Pritzker School of Medicine, Chicago, IL, USA.
Imyanitov EN; N.N. Petrov Institute of Oncology, St. Petersburg, Russia.
Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Izatt L; Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Izquierdo A; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), ONCOBELL-IDIBELL-IGTP, CIBERONC, Barcelona, Spain.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
James PA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
Janavicius R; Faculty of Medicine, Institute of Biomedical Sciences, Dept. Of Human and Medical Genetics, Vilnius University, Vilnius, Lithuania.; State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
John EM; Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Joseph V; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Karlan BY; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA.
Kemp Z; Breast and Cancer Genetics Units, The Royal Marsden NHS Foundation Trust, London, UK.
Kirk J; Familial Cancer Service, Weatmead Hospital, Wentworthville, New South Wales, Australia.
Konstantopoulou I; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece.
Koudijs M; Department of Medical Genetics, University Medical Center, Utrecht, The Netherlands.
Kwong A; Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong, China.; Department of Surgery, The University of Hong Kong, Hong Kong, China.; Department of Surgery and Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong, China.
Laitman Y; The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.
Lalloo F; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Lasset C; Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France.
Lautrup C; Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark.
Lazaro C; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), ONCOBELL-IDIBELL-IGTP, CIBERONC, Barcelona, Spain.
Legrand C; Département de Génétique, CHU de Grenoble, Grenoble, France.
Leslie G; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Lesueur F; Genetic Epidemiology of Cancer team, Inserm U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.
Mai PL; Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Manoukian S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Mari V; Département d'Hématologie-Oncologie Médicale, Centre Antoine Lacassagne, Nice, France.
Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Mebirouk N; Genetic Epidemiology of Cancer team, Inserm U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.
Meindl A; Department of Gynecology and Obstetrics, University of Munich, Campus Großhadern, Munich, Germany.
Miller A; NRG Oncology, Statistics and Data Management Center, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Montagna M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Moserle L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Mouret-Fourme E; Service de Génétique, Institut Curie, Paris, France.
Musgrave H; Department of Clinical Genetics, Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.
Nambot S; Unité d'oncogénétique, Centre de Lutte Contre le Cancer, Centre Georges-François Leclerc, Dijon, France.
Nathanson KL; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Yie JNY; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Cancer Genetics Service, National Cancer Centre, Singapore, Singapore.
Nguyen-Dumont T; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
Nikitina-Zake L; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Offit K; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
Olopade OI; Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA.
Osorio A; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO) and Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.
Ott CE; Institute of Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.; Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, South Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Pedersen IS; Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Peixoto A; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
Perez-Segura P; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
Peterlongo P; Genome Diagnostics Program, IFOM ETS - the AIRC Institute of Molecular Oncology, Milan, Italy.
Pocza T; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Ramser J; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Rantala J; Clinical Genetics, Karolinska Institutet, Stockholm, Sweden.
Rodriguez GC; Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL, USA.
Rønlund K; Department of Clinical Genetics, University Hospital of Southern Denmark, Vejle Hospital, Vejle, Denmark.
Rosenberg EH; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Rossing M; Center for Genomic Medicine, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Schmutzler RK; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Shah PD; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Sharif S; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Birmingham, UK.
Sharma P; Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, KS, USA.
Side LE; Princess Anne Hospital, Southampton, UK.
Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, QC, Canada.
Singer CF; Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Snape K; Medical Genetics Unit, St George's, University of London, London, UK.
Steinemann D; Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
Stoppa-Lyonnet D; Service de Génétique, Institut Curie, Paris, France.; Department of Tumour Biology, INSERM U830, Paris, France.; Université Paris Cité, Paris, France.
Sutter C; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
Tan YY; Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Teixeira MR; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.; Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.
Teo SH; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark.
Thull DL; Department of Medicine, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Tischkowitz M; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, Canada.; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
Toland AE; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
Trainer AH; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Department of medicine, University Of Melbourne, Melbourne, Victoria, Australia.
Tripathi V; South East Thames Regional Genetics Service, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Tung N; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
van Engelen K; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
van Rensburg EJ; Department of Genetics, University of Pretoria, Arcadia, South Africa.
Vega A; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
Viel A; Division of Functional onco-genomics and genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Walker L; Oxford Regional Genetics Service, Churchill Hospital, Oxford, UK.
Weitzel JN; Latin American School of Oncology, Tuxtla Gutiérrez, Chiapas, Mexico.
Wevers MR; Radboud University Medical Center, Nijmegen, Netherlands.
Chenevix-Trench G; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Walker LC; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand. .; Pokaż więcej
Corporate Authors:: GEMO Study Collaborators
EMBRACE Collaborators
SWE-BRCA Investigators
kConFab Investigators
HEBON Investigators
Źródło:: Communications biology [Commun Biol] 2022 Oct 06; Vol. 5 (1), pp. 1061. Date of Electronic Publication: 2022 Oct 06.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; DNA Copy Number Variations ; Female ; Genetic Predisposition to Disease ; Heterozygote ; Humans ; RNA, Messenger

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Pathobiologic Stratification of Oncotype DX Recurrence Scores and Comparative Validation of 3 Surrogate Models.
Autorzy:: Mohamed A; From the Department of Pathology and Laboratory Medicine (Mohamed, Kousar, Geradts), East Carolina University Brody School of Medicine, Greenville, North Carolina.
Kousar A; From the Department of Pathology and Laboratory Medicine (Mohamed, Kousar, Geradts), East Carolina University Brody School of Medicine, Greenville, North Carolina.
Wong J; From Department of Surgery (Wong, Vohra), East Carolina University Brody School of Medicine, Greenville, North Carolina.
Vohra N; From Department of Surgery (Wong, Vohra), East Carolina University Brody School of Medicine, Greenville, North Carolina.
Muzaffar M; From the Department of Medical Oncology (Muzaffar), East Carolina University Brody School of Medicine, Greenville, North Carolina.
Geradts J; From the Department of Pathology and Laboratory Medicine (Mohamed, Kousar, Geradts), East Carolina University Brody School of Medicine, Greenville, North Carolina.; Pokaż więcej
Źródło:: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2022 Oct 01; Vol. 146 (10), pp. 1258-1267.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Receptors, Progesterone*/metabolism
Biomarkers, Tumor/genetics ; Female ; Gene Expression Profiling/methods ; Humans ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Receptors, Estrogen/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Shared decision-making in routine breast cancer care in Germany-A cross-sectional study.
Autorzy:: Feiten S; Institut für Versorgungsforschung in der Onkologie, Koblenz, Germany.
Scholl I; Institut und Poliklinik für Medizinische Psychologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Dünnebacke J; Brustzentrum Marienhof, Katholisches Klinikum Koblenz-Montabaur, Koblenz, Germany.
Schmidt M; Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Universitätsmedizin Mainz, Mainz, Germany.
Franzen A; Brustzentrum Kemperhof, Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany.
Ernst W; Brustzentrum St. Elisabeth, Gemeinschaftsklinikum Mittelrhein, Mayen, Germany.
Spaderna H; Abteilung Gesundheitspsychologie, Pflegewissenschaft, Universität Trier, Trier, Germany.
Weide R; Praxis für Hämatologie und Onkologie, Koblenz, Germany.; Pokaż więcej
Źródło:: Psycho-oncology [Psychooncology] 2022 Jul; Vol. 31 (7), pp. 1120-1126. Date of Electronic Publication: 2022 Feb 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/therapy
Decision Making, Shared*
Cross-Sectional Studies ; Decision Making ; Female ; Germany ; Humans ; Middle Aged ; Patient Participation ; Physician-Patient Relations

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Breast cancer risks associated with missense variants in breast cancer susceptibility genes.
Autorzy:: Dorling L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Carvalho S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Allen J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
Fortuno C; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
González-Neira A; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.
Heijl SM; Bio-Prodict, Nijmegen, The Netherlands.
Adank MA; Family Cancer Clinic, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Amsterdam, 1066 CX, The Netherlands.
Ahearn TU; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20850, USA.
Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, M5S 1A8, Canada.
Auvinen P; Translational Cancer Research Area, University of Eastern Finland, 70210, Kuopio, Finland.; Institute of Clinical Medicine, Oncology, University of Eastern Finland, 70210, Kuopio, Finland.; Department of Oncology, Cancer Center, Kuopio University Hospital, 70210, Kuopio, Finland.
Becher H; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
Beckmann MW; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), 91054, Erlangen, Germany.
Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Bermisheva M; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, 450054, Russia.
Bogdanova NV; Department of Radiation Oncology, Hannover Medical School, 30625, Hannover, Germany.; Gynaecology Research Unit, Hannover Medical School, 30625, Hannover, Germany.; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, 223040, Minsk, Belarus.
Bojesen SE; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730, Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Bremer M; Department of Radiation Oncology, Hannover Medical School, 30625, Hannover, Germany.
Briceno I; Medical Faculty, Universidad de La Sabana, 140013, Bogota, Colombia.
Camp NJ; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA.
Campbell A; Centre for Genomic and Experimental Medicine, Institute of Genetics & Cancer, The University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK.; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, EH16 4UX, UK.
Castelao JE; Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, 36312, Vigo, Spain.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
Chanock SJ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20850, USA.
Chenevix-Trench G; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
Collée JM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, 3015 CN, The Netherlands.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65, Stockholm, Sweden.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Dörk T; Gynaecology Research Unit, Hannover Medical School, 30625, Hannover, Germany.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65, Stockholm, Sweden.
Evans DG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.; Nightingale & Genesis Prevention Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, M23 9LT, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.
Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), 91054, Erlangen, Germany.; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
Figueroa J; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20850, USA.; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, EH16 4UX, UK.; Cancer Research UK Edinburgh Centre, The University of Edinburgh, Edinburgh, EH4 2XR, UK.
Flyger H; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730, Herlev, Denmark.
Gabrielson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65, Stockholm, Sweden.
Gago-Dominguez M; Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, , 15706, Santiago de Compostela, Spain.; Moores Cancer Center, University of California San Diego, La Jolla, CA, 92037, USA.
García-Closas M; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20850, USA.
Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, 3004, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, 3010, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, 3168, Australia.
Glendon G; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada.
Guénel P; Team 'Exposome and Heredity', CESP, Inserm, Gustave Roussy, University Paris-Saclay, UVSQ, Villejuif, France.
Gündert M; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, 69120, Heidelberg, Germany.; Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764, Neuherberg, Germany.
Hadjisavvas A; Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 2371, Nicosia, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, 2371, Nicosia, Cyprus.
Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65, Stockholm, Sweden.; Department of Oncology, 118 83, Södersjukhuset, Stockholm, Sweden.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Harkness EF; Nightingale & Genesis Prevention Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, M23 9LT, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.; Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK.
Hartman M; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, 117549, Singapore.; Department of Surgery, National University Health System, Singapore, 119228, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, 119228, Singapore.
Hogervorst FBL; Family Cancer Clinic, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Amsterdam, 1066 CX, The Netherlands.
Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, 3015 GD, The Netherlands.
Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376, Stuttgart, Germany.; University of Tübingen, 72074, Tübingen, Germany.
Howell A; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.; Division of Cancer Sciences, University of Manchester, Manchester, M13 9PL, UK.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, 71-252, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, 71-252, Szczecin, Poland.
Jung A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Khusnutdinova E; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, 450054, Russia.; Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, 450000, Russia.
Kim SW; Department of Surgery, Daerim Saint Mary's Hospital, Seoul, 07442, Korea.
Ko YD; Department of Internal Medicine, Johanniter GmbH Bonn, Johanniter Krankenhaus, 53113, Bonn, Germany.
Kristensen VN; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0450, Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital and University of Oslo, 0379, Oslo, Norway.
Lakeman IMM; Department of Human Genetics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.; Department of Clinical Genetics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Li J; Department of Surgery, National University Health System, Singapore, 119228, Singapore.; Human Genetics Division, Genome Institute of Singapore, Singapore, 138672, Singapore.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Loizidou MA; Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, 2371, Nicosia, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, 2371, Nicosia, Cyprus.
Lophatananon A; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK.
Lubiński J; Department of Genetics and Pathology, Pomeranian Medical University, 71-252, Szczecin, Poland.
Luccarini C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
Madsen MJ; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA.
Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, 70210, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, 70210, Kuopio, Finland.; Biobank of Eastern Finland, Kuopio University Hospital, Kuopio, Finland.
Manoochehri M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Margolin S; Department of Oncology, 118 83, Södersjukhuset, Stockholm, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 118 83, Stockholm, Sweden.
Mavroudis D; Department of Medical Oncology, University Hospital of Heraklion, 711 10, Heraklion, Greece.
Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, 3004, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, 3010, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, 3168, Australia.
Mohd Taib NA; Breast Cancer Research Unit, Faculty of Medicine, University Malaya Cancer Research Institute, University of Malaya, 50603, Kuala Lumpur, Malaysia.; Department of Surgery, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.
Muir K; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, 00290, Helsinki, Finland.
Newman WG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK.
Oosterwijk JC; Department of Genetics, University Medical Center Groningen, University Groningen, Groningen, 9713 GZ, The Netherlands.
Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, 03080, Korea.; Convergence Graduate Program in Innovative Medical Science, Seoul National University College of Medicine, Seoul, 03080, South Korea.; Cancer Research Institute, Seoul National University, Seoul, 03080, Korea.
Peterlongo P; Genome Diagnostics Program, IFOM - the FIRC Institute of Molecular Oncology, 20139, Milan, Italy.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), 20133, Milan, Italy.
Saloustros E; Department of Oncology, University Hospital of Larissa, 411 10, Larissa, Greece.
Sawyer EJ; School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, King's College London, London, UK.
Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931, Cologne, Germany.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
Sim X; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, 117549, Singapore.
Southey MC; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, 3004, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, 3168, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, 3010, Australia.
Surowy H; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, 69120, Heidelberg, Germany.
Suvanto M; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, 00290, Helsinki, Finland.
Tomlinson I; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, OX3 7BN, UK.
Torres D; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Institute of Human Genetics, Pontificia Universidad Javeriana, 110231, Bogota, Colombia.
Truong T; Team 'Exposome and Heredity', CESP, Inserm, Gustave Roussy, University Paris-Saclay, UVSQ, Villejuif, France.
van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Waltes R; Gynaecology Research Unit, Hannover Medical School, 30625, Hannover, Germany.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Yang XR; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20850, USA.
Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Amsterdam, 1066 CX, The Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Amsterdam, 1066 CX, The Netherlands.
Benitez J; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Biomedical Network On Rare Diseases (CIBERER), 28029, Madrid, Spain.
Vroling B; Bio-Prodict, Nijmegen, The Netherlands.; Centre for Molecular and Biomolecular Informatics (CMBI), Radboud University Medical Center, Nijmegen, The Netherlands.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK.
Teo SH; Breast Cancer Research Unit, Faculty of Medicine, University Malaya Cancer Research Institute, University of Malaya, 50603, Kuala Lumpur, Malaysia.; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, 47500, Selangor, Malaysia.
Kvist A; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, 22381, Lund, Sweden.
de la Hoya M; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040, Madrid, Spain.
Devilee P; Department of Human Genetics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
Vreeswijk MPG; Department of Human Genetics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK. .; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK. .; Pokaż więcej
Corporate Authors:: NBCS Collaborators
kConFab Investigators
SGBCC Investigators
Źródło:: Genome medicine [Genome Med] 2022 May 18; Vol. 14 (1), pp. 51. Date of Electronic Publication: 2022 May 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/genetics
Case-Control Studies ; Female ; Genetic Predisposition to Disease ; Humans ; Mutation, Missense

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer.
Autorzy:: Claessens AKM; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Busschbach JJV; Department of Psychiatry, Section of Medical Psychology and Psychotherapy, Erasmus Medical Centre, Rotterdam, The Netherlands.
Ramaekers BLT; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands.
Erdkamp FLG; Department of Medical Oncology, Zuyderland Medical Centre, Geleen, The Netherlands.
Bouma JM; Department of Trial Registration, Comprehensive Cancer Centre the Netherlands, Rotterdam, The Netherlands.
van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands.
Tjan-Heijnen VCG; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Bos MEMM; Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands.; Pokaż więcej
Corporate Authors:: Dutch Breast Cancer Research Group (BOOG)
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 May; Vol. 61 (5), pp. 619-624. Date of Electronic Publication: 2022 Feb 09.
Typ publikacji:: Letter
MeSH Terms:: Breast Neoplasms*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cost-Benefit Analysis ; Female ; Humans ; Receptor, ErbB-2 ; Trastuzumab/therapeutic use

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Vitamin D May Protect against Breast Cancer through the Regulation of Long Noncoding RNAs by VDR Signaling.
Autorzy:: Blasiak J; Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland.
Chojnacki J; Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, 90-647 Lodz, Poland.
Pawlowska E; Department of Orthodontics, Medical University of Lodz, 92-217 Lodz, Poland.
Jablkowska A; Department of Internal Diseases and Cardiology, H. Jonscher Hospital, 93-113 Lodz, Poland.
Chojnacki C; Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, 90-647 Lodz, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Mar 16; Vol. 23 (6). Date of Electronic Publication: 2022 Mar 16.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Breast Neoplasms*/metabolism
RNA, Long Noncoding*/genetics
Animals ; Calcitriol/pharmacology ; Cholecalciferol ; Female ; Humans ; Receptors, Calcitriol/genetics ; Receptors, Calcitriol/metabolism ; Signal Transduction ; Vitamin D/metabolism ; Vitamins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Tumor-infiltrating lymphocytes predict improved overall survival after post-mastectomy radiotherapy: a study of the randomized DBCG82bc cohort.
Autorzy:: Tramm T; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Vinter H; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Vahl P; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Özcan D; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Alsner J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Overgaard J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.; Pokaż więcej
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Feb; Vol. 61 (2), pp. 153-162. Date of Electronic Publication: 2021 Oct 27.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Breast Neoplasms*/radiotherapy
Lymphocytes, Tumor-Infiltrating*/pathology
Disease-Free Survival ; Female ; Humans ; Mastectomy ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Radiotherapy, Adjuvant ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Symptom trajectories in breast cancer survivors: growth mixture analysis of patient-reported pain, fatigue, insomnia, breast and arm symptoms.
Autorzy:: Nielsen AWM; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Lundorff M; Unit for Psychooncology and Health Psychology, Department of Psychology and Behavioural Sciences, Aarhus University, Aarhus, Denmark.
Nielsen HM; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Alsner J; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Vrou Offersen B; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Kristensen MH; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Zachariae R; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.; Unit for Psychooncology and Health Psychology, Department of Psychology and Behavioural Sciences, Aarhus University, Aarhus, Denmark.; Pokaż więcej
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2021 Dec; Vol. 60 (12), pp. 1659-1667. Date of Electronic Publication: 2021 Sep 28.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/therapy
Cancer Survivors*
Sleep Initiation and Maintenance Disorders*/epidemiology
Sleep Initiation and Maintenance Disorders*/etiology
Arm ; Fatigue/epidemiology ; Fatigue/etiology ; Female ; Humans ; Middle Aged ; Pain/epidemiology ; Pain/etiology ; Patient Reported Outcome Measures ; Quality of Life ; Survivors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Manipulating Estrogenic/Anti-Estrogenic Activity of Triphenylethylenes towards Development of Novel Anti-Neoplastic SERMs.
Autorzy:: Elnakib HE; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt.
Ramsis MM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt.
Albably NO; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt.
Vector MA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt.
Weigand JJ; Faculty of Chemistry and Food Chemistry, Institute of Inorganic Molecular Chemistry, Technische Universität Dresden, 01062 Dresden, Germany.
Schwedtmann K; Faculty of Chemistry and Food Chemistry, Institute of Inorganic Molecular Chemistry, Technische Universität Dresden, 01062 Dresden, Germany.
Wober J; Faculty of Biology, Institute of Zoology, Technische Universität Dresden, 01062 Dresden, Germany.
Zierau O; Faculty of Biology, Institute of Zoology, Technische Universität Dresden, 01062 Dresden, Germany.
Vollmer G; Faculty of Biology, Institute of Zoology, Technische Universität Dresden, 01062 Dresden, Germany.
Abadi AH; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt.
Ahmed NS; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Nov 22; Vol. 22 (22). Date of Electronic Publication: 2021 Nov 22.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms/*drug therapy
Endometrial Neoplasms/*drug therapy
Estrogen Receptor alpha/*genetics
Selective Estrogen Receptor Modulators/*pharmacology
Tamoxifen/*pharmacology
Animals ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Endometrial Neoplasms/genetics ; Endometrial Neoplasms/pathology ; Estrogen Antagonists/chemical synthesis ; Estrogen Antagonists/pharmacology ; Female ; Humans ; MCF-7 Cells ; Rats ; Receptors, Estrogen/antagonists & inhibitors ; Receptors, Estrogen/genetics ; Selective Estrogen Receptor Modulators/chemical synthesis ; Stilbenes/chemical synthesis ; Stilbenes/pharmacology ; Tamoxifen/analogs & derivatives

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study.
Autorzy:: Zheng G; Center for Primary Health Care Research, Lund University/Region Skåne, Jan Waldenströms gata 35, 205 02, Malmö, Sweden. .
Sundquist J; Center for Primary Health Care Research, Lund University/Region Skåne, Jan Waldenströms gata 35, 205 02, Malmö, Sweden.; Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA.; Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Izumo, Japan.
Sundquist K; Center for Primary Health Care Research, Lund University/Region Skåne, Jan Waldenströms gata 35, 205 02, Malmö, Sweden.; Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA.; Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Izumo, Japan.
Ji J; Center for Primary Health Care Research, Lund University/Region Skåne, Jan Waldenströms gata 35, 205 02, Malmö, Sweden.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Nov 12; Vol. 21 (1), pp. 1210. Date of Electronic Publication: 2021 Nov 12.
Typ publikacji:: Journal Article
MeSH Terms:: Family Health*
Breast Neoplasms/*epidemiology
Neoplasms, Second Primary/*epidemiology
Age of Onset ; Aged ; Cohort Studies ; Female ; Humans ; Incidence ; Information Storage and Retrieval ; Middle Aged ; Neoplasms/epidemiology ; Parents ; Pedigree ; Poisson Distribution ; Registries ; Risk ; Siblings ; Sweden/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Jan, J."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język